LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.62 | 21.74 | 3109 | 4150 | 0.7490 | 0.9252 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.62 | 21.74 | 3734 | 4150 | 0.8996 | 0.9723 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.62 | 21.74 | 3779 | 4150 | 0.9104 | 0.9754 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.59 | 21.74 | 3313 | 4492 | 0.7375 | 0.9224 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.59 | 21.74 | 3340 | 4492 | 0.7435 | 0.9244 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.59 | 21.74 | 4011 | 4492 | 0.8929 | 0.9708 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.59 | 21.74 | 4055 | 4492 | 0.9027 | 0.9736 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.56 | 21.74 | 3608 | 4838 | 0.7456 | 0.9261 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.56 | 21.74 | 3632 | 4838 | 0.7506 | 0.9278 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.56 | 21.74 | 4261 | 4838 | 0.8806 | 0.9677 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.56 | 21.74 | 4301 | 4838 | 0.8889 | 0.9700 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.53 | 21.74 | 3806 | 5150 | 0.7389 | 0.9247 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.53 | 21.74 | 3834 | 5150 | 0.7444 | 0.9265 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.53 | 21.74 | 4527 | 5150 | 0.8789 | 0.9675 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.53 | 21.74 | 4564 | 5150 | 0.8861 | 0.9696 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.50 | 21.74 | 4057 | 5425 | 0.7477 | 0.9283 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.50 | 21.74 | 4090 | 5425 | 0.7538 | 0.9303 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.50 | 21.74 | 4764 | 5425 | 0.8780 | 0.9676 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.50 | 21.74 | 4795 | 5425 | 0.8837 | 0.9692 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.48 | 21.74 | 4263 | 5768 | 0.7390 | 0.9263 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.48 | 21.74 | 4287 | 5768 | 0.7431 | 0.9276 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.48 | 21.74 | 5135 | 5768 | 0.8901 | 0.9713 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.48 | 21.74 | 5166 | 5768 | 0.8955 | 0.9728 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 57.45 | 21.74 | 4486 | 6023 | 0.7447 | 0.9287 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 57.45 | 21.74 | 4515 | 6023 | 0.7496 | 0.9302 | MN20160310_N01 | C03 |